Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-26-000083
Filing Date
2026-08-06
Accepted
2026-08-06 08:32:28
Documents
64
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20260630.htm   iXBRL 10-Q 980164
2 EX-31.1 exhibit31120260630.htm EX-31.1 11976
3 EX-31.2 exhibit31220260630.htm EX-31.2 12783
4 EX-32.1 exhibit32120260630.htm EX-32.1 10421
  Complete submission text file 0001689548-26-000083.txt   5861372

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20260630.xsd EX-101.SCH 40336
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20260630_cal.xml EX-101.CAL 60355
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20260630_def.xml EX-101.DEF 190958
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20260630_lab.xml EX-101.LAB 555989
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20260630_pre.xml EX-101.PRE 366925
68 EXTRACTED XBRL INSTANCE DOCUMENT prax-20260630_htm.xml XML 766047
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 261246248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)